Genericart Medicine Private Limited, a active private limited company, was established on 02 February 2016 in Miraj, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290PN2016PTC158184. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.98 Cr.
It upholds a compliant status. Employing 102 professional, Its leadership includes Taherin Salim Sayyed (Director), Smita Shripad Kolhatkar (Director), Salim Ansar Sayyad (Director). Past directors included Taherin Salim Sayyed, Smita Shripad Kolhatkar. It holds ₹5.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Genericart House, New S. No. 224/2, Bhokare Colony Opp. Reliance Petrol Pump, Chandanwadi, Miraj, Maharashtra, 416410.
U24290PN2016PTC158184
158184
02 February 2016
₹2.00 Cr
₹1.98 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Genericart Medicine Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Taherin Salim Sayyed | Director | 01 Jul 2020 | Current |
| Smita Shripad Kolhatkar | Director | 01 Jul 2020 | Current |
| Salim Ansar Sayyad | Director | 02 Feb 2016 | Current |
| Shripad Manohar Kolhatkar | Director | 02 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 07 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 07 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genericart Medicine Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.29% increase. The company also saw a substantial fall in profitability, with a 74.48% decrease in profit. The company's net worth moved up by a moderate rise of 7.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Genericart Medicine had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹57,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2022 | Others | ₹5.75 Cr | Open |
Explore comprehensive loan charge details -
Genericart Medicine has a workforce of 102 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Genericart Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genericart Medicine's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Genericart Medicine Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Genericart Medicine Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 5.75 Cr with Charge ID 100532798 was registered on 04 Feb 2022. was documented.
Taherin Salim Sayyed was appointed as a Director was appointed as a Director on 01 Jul 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
The activity Smita Shripad Kolhatkar was appointed as a Director was appointed as a Director on 01 Jul 2020 & has been associated with this company since 5 years 5 months . was completed.
Salim Ansar Sayyad was appointed as a Director was appointed as a Director on 02 Feb 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.
The CIN of Genericart Medicine Private Limited is U24290PN2016PTC158184.
Genericart Medicine Private Limited is headquartered at Genericart House, New S. No. 224/2, Bhokare Colony Opp. Reliance Petrol Pump, Chandanwadi, Miraj, Maharashtra, 416410.
Genericart Medicine Private Limited was incorporated on 02 February 2016.
The current directors of Genericart Medicine Private Limited are
The primary industry of Genericart Medicine Private Limited is Trade.
Genericart Medicine Private Limited is unlisted.
The authorized capital of Genericart Medicine Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.98 Cr.
The compliance status of Genericart Medicine Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX